Meet our Senior Management team
Emer Clarke, PhD | Co-Founder & CSO
Dr. Clarke has over 25 years of experience in the stem cell biology field in both clinical and industrial settings. As ReachBio Research Labs CSO, Dr. Clarke is instrumental in managing the scientific operations of the company including research and development and client services. She is engaged in client affairs through one-on-one consultation, study design and data analysis.
Previously, Dr. Clarke was a member of the senior management team at StemCell Technologies, Inc. as Scientific Director of Contract Services and Manager of Education. Prior to this, Dr. Clarke was employed as Senior Clinical Scientist in the Cell Processing Unit at the National Blood Centre in Bristol UK. She was responsible for leading research on the evaluation of new cell therapy protocols for treatment of childhood leukemia and other hematopoietic diseases. Earlier, Dr. Clarke was employed at Cell Therapeutics Inc. (CTI BioPharma) as an Associate Scientist performing primary cell-based assays in support of the company’s drug screening programs.
Rob Chaney | Co-Founder, COO & General Manager
Mr. Chaney is responsible for the overall operations of the company and works with other senior members addressing business development and marketing concerns. Mr. Chaney has over 18 years experience in sales, marketing, operations and business development in the life sciences sector.
Before joining ReachBio Research Labs, he was at StemCell Technologies, Inc. for almost 10 years where he held a number of key positions in sales and business development. For the final 3 years of his tenure there, Mr. Chaney was the Business Director of the Contract Services Division.
Prior to his business experience, Mr. Chaney was employed in various laboratory based positions in clinical and industrial research involving, among other research interests, applications of cell-based assays in blood screening (pathogen) and inflammation.
Specialties: operations, sales and business development expertise in preclinical contract services (CRO) industry, knowledge and experience in stem cell and primary cell markets.